Differential regulation of microglial activation by propentofylline via cAMP signaling

Brain Research

Volumn 812, Issue 1-2, 1998, Pages 97-104

  Si, Qiusheng ^a   Nakamura, Yoichi ^a   Ogata, Tadanori ^a   Kataoka, Kiyoshi ^a   Schubert, Peter ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

Cytokines; Dibutyryl cAMP; Microgila; Nitric oxide; Propentofylline; Superoxide

Indexed keywords

BUCLADESINE; CYCLIC AMP; INTERLEUKIN 1BETA; NITRIC OXIDE; PROPENTOFYLLINE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CELL ACTIVATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DRUG EFFECT; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BUCLADESINE; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICROGLIA; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; RATS; SIGNAL TRANSDUCTION; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA; XANTHINES;

EID: 0032561712     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00954-8     Document Type: Article

References (36)

1. Aderka D., Le J.M., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:1989;3517-3523.
2. Banati R.B., Schubert P., Rothe G., Gehrmann J., Rudolphi K., Valet G., Kreutzberg G.W. Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J. Cereb. Blood Flow Metab. 14:1994;145-149.
3. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-α. A mediator of focal ischemic brain injury. Stoke. 28:1997;1233-1244.
4. Brett J., Gerlach H., Nawroth P., Steinburg S., Godman G., Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G protein. J. Exp. Med. 169:1989;1977-1991.
5. Chao C.C., Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16:1994;172-179.
6. Chao C.C., Hu S., Peterson P.K. Glia: the not so innocent bystanders. J. Neurobiol. 2:1996;234-239.
7. Das S., Potter H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron. 14:1995;447-456.
8. Ferroni S., Marchini C., Schubert P., Rapisarda C. Two distinct inwardly rectifying conductances are expressed in cultured rat cortical astrocytes after long term dibutyryl-cyclic-AMP treatment. FEBS Lett. 367:1995;319-325.
9. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol. Brain. Res. 16:1992;128-134.
10. Frei K., Malipiero U.V., Leist T.P., Zinkernagel R.M., Schwab M.E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:1989;689-694.
11. Giulian D. Ameboid microglia as effector of inflammation in the central nervous system. J. Neurosci. Res. 18:1987;155-171.
12. Hewett S.J., Csernansky C.A., Choi D.W. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron. 13:1994;487-494.
13. Kim K.S., Wass C.A., Cross A.S., Opal S.M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 11:1992;293-298.
14. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.-S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
15. Ma J., Yee A., Brewer H.B. Jr., Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 372:1994;92-94.
16. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S.D., Ohtsuki T., Kinoshita T., Kamada T., Stern D.M. Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J. Exp. Med. 180:1994;2297-2308.
17. Matsuda S., Wen T.C., Morita F., Otsuka H., Igase K., Yoshimura H., Sakanaka M. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci. Lett. 204:1996;109-112.
18. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegerative diseases. Brain Res. Rev. 21:1995;195-218.
19. Meskini N., Nëmoz G., Okyayuz-Baklouti I., Lagarde M., Prigent A.F. Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on peripheral microcirculation. Biochem. Pharmacol. 47:1994;781-788.
20. Nagata K., Ogawa T., Omosu M., Fujimoto K., Hayashi S. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity. Arzneimittelforschung. 35:1985;1034-1036.
21. Nitta A., Ogihara Y., Onishi J., Hasegawa T., Furukawa S., Nabeshima T. Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by theinfusion of anti-NGF antibody into the rat septum. Behav. Brain Res. 83:1997;201-204.
22. Nawashiro H., Tasaki K., Ruetzler C.A., Hallenbeck J.M. TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17:1997;483-490.
23. Ohtake A., Tabata S., Hayashi S. Blood-brain transfer of propentofylline and its metabolites in rats. J. Biopharm. Sci. 1:1990;159-170.
24. Parkinson F.E., Rudolphi K.A., Fredholm B.B. Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen. Pharmacol. 25:1994;1053-1058.
25. Righi M. Modulation of cytokine expression by cAMP analogs in myc-immortalized microglial cell lines. Func. Neurol. 8:1993;359-363.
26. Rudolphi K.A., Schubert P. Modulation of neuronal and glial cell function by adenosine and neuroprotection in vascular dementia. Behav. Brain Res. 83:1997;123-128.
27. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro Ann. Neurology. 23:1988;339-346.
28. Schubert P., Ogata T., Ferroni S., McRae A., Nakamura Y., Rudolphi K. Modulation of glial cell singnaling by adenosine and pharmacological reinforcement. A neuroprotective strategy? Mol. Chem. Neuropathol. 28:1996;185-190.
29. Schubert P., Ogata T., Rudolphi K., Marchini C., McRae A., Ferroni S. Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline. Ann. NY Acad. Sci. 826:1997;337-347.
30. Schultze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacobs W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267:1992;5317-5323.
31. Shinoda I., Furukawa Y., Furukawa S. Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol. 39:1990;1813-1816.
32. Si Q.S., Nakamura Y., Schubert P., Rudolphi K., Kataoka K. Adenosine and propentofylline inhibit the proliferation of cultured microglial cells. Exp. Neurol. 137:1996;345-349.
33. Si Q.S., Nakamura Y., Kataoka K. Adenosine inhibits superoxide production in rat peritoneal macrophages via elevation of cAMP level. Immunopharmacology. 36:1997;1-7.
34. Si Q.S., Nakamura Y., Kataoka K. Hypothermic suppression of microglial activation in culture: inhibition of cell proliferation and production of nitric oxide and superoxide. Neuroscience. 81:1997;223-229.
35. Si Q.S., Nakamura Y., Kataoka K. Albumin enhance superoxide production in cultured microglia. Glia. 21:1997;413-418.
36. Suzumura A., Sawada M., Marunouchi T. Propentofylline suppresses TNF-alpha production by glial cells. Neuroimmunology. 3:1995;76-77.